Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Gilead Sciences, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
GILD
Nasdaq
2834
https://www.gilead.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
- May 10th, 2024 1:00 pm
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
- May 9th, 2024 8:05 pm
Gilead's FOCUS Program Helps Zero In on Early HIV Detection
- May 9th, 2024 1:45 pm
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
- May 9th, 2024 5:07 am
Gilead Helps Put African Nation on Path To Eliminate Hepatitis C
- May 7th, 2024 1:45 pm
Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024
- May 7th, 2024 12:30 pm
23 Most Profitable Stocks of the Last 12 Months
- May 4th, 2024 11:38 am
Forbes Has Listed Gilead as One of America’s Best Employers for Diversity
- May 3rd, 2024 6:00 pm
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
- May 3rd, 2024 9:08 am
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
- May 2nd, 2024 2:02 pm
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
- May 1st, 2024 6:38 pm
Gilead Sciences to Present at Upcoming Investor Conferences
- Apr 30th, 2024 8:05 pm
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
- Apr 30th, 2024 4:01 pm
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
- Apr 29th, 2024 1:00 pm
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
- Apr 29th, 2024 10:01 am
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
- Apr 27th, 2024 2:29 pm
Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
- Apr 26th, 2024 8:10 pm
Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
- Apr 26th, 2024 2:24 pm
Q1 2024 Gilead Sciences Inc Earnings Call
- Apr 26th, 2024 12:11 pm
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
- Apr 26th, 2024 12:00 pm
Scroll